Acronym |
  |
Trial Name |
|
|
|
Appropriate Blood pressure Control in Diabetes – Part 2 with Valsartan |
|
|
Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes |
|
|
Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events |
|
|
Amlodipine Versus Angiotensin II receptor blocker: Control of blood pressure Evaluation trial in Diabetics – Japan |
|
|
Atrial Fibrillation and Congestive Heart Failure |
|
|
Albumin in Acute Stroke |
|
|
Assessment of Lipophilic vs hydrophilic Statin therapy in Acute Myocardial Infarction |
|
|
Australian National Blood Pressure study 2 |
|
|
Angiotensin II antagonist In Paroxysmal Atrial Fibrillation |
|
|
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure |
|
|
Aspirin non-responsiveness and Clopidogrel Endpoint Trial |
|
|
Aortic Stenosis progression Observation: Measuring Effects of Rosuvastatin |
|
|
Anticoagulation and Risk factors In Atrial fibrillation |
|
|
|
|
|
Carotid Atorvastatin Study in Hyperlipidemic post-Menopausal women |
|
|
Second Chinese Cardiac Study |
|
|
Comparison of the Effects Noted in the ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acute coronary Syndrome |
|
|
Cortisone plus BMS or DES versus BMS alone to eliminate restenosis |
|
|
Controlling Hypertension and Hypotension Immediately Post-Stroke |
|
|
China Intensive Lipid Lowering with statins in Acute coronary Syndrome |
|
|
Chinese Medicine Neuroaid® Efficacy on Stroke recovery |
|
|
Comparison of Intracoronary versus intravenous abciximab administration during Emergency Reperfusion Of ST-segment elevation myocardial infarction |
|
|
Copenhagen Insulin and Metformin Therapy |
|
|
Clopidogrel to Improve Primary percutaneous coronary intervention in Acute Myocardial Infarction |
|
|
Combination therapy of hypertension to Prevent cardiovascular Events |
|
|
Continue Or Stop post-Stroke Antihypertensives Collaborative Study |
|
|
Coronary Prevention and Hypertension Research Project |
|
|
Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin beta |
|
|
Chronic Renal Insufficiency Cohort |
|
|
Clopidogrel optimal loading dose Usage to Reduce Recurrent Events – Organisation to Assess Strategies in Ischaemic Syndromes 7 |
|
|
Diabetic Atherosclerosis Prevention by Cilostazol |
|
|
Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation Acute Coronary Syndrome |
|
|
Ezetimibe and Simvastatin in Hypercholesterolemia Enhances atherosclerosis regression |
|
|
Efficacy of Nitric Oxide in Stroke |
|
|
European Risk and Incidence, a Coordinated Analysis |
|
|
Early Self Controlled Anticoagulation Trial II |
|
|
Efficacy of Xience/promus versus Cypher in reducing Late Loss after stenting |
|
|
Extended Clinical prophylaxis in Acutely Ill Medical patients |
|
|
Fluvastatin in the therapy of Acute Coronary Syndrome |
|
|
Fosinopril in Dialysis |
|
|
Follow-Up Serial Infusions Of Nesiritide II |
|
|
Glucose-Insulin-Potassium Study – 2 |
|
|
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocradico – Atrial Fibrillation |
|
|
Gauging Responsiveness with A VerifyNow assay – Impact on Thrombosis And Safety |
|
|
Hypertension in Diabetes Study |
|
|
Heart failure revascularisation trial |
|
|
High-risk and Population strategy for Occupational Health Promotion |
|
|
High-density lipoprotein Intervention Trial |
|
|
Hypertension Objective treatment based on Measurement by Electrical Devices of BP |
|
|
Investigation on Colchicine for Acute Pericarditis |
|
|
Isfahan Healthy Heart Programme |
|
|
Irbesartan in the Management of Proteinuric patients at high risk for Vascular Events |
|
|
Improved Reduction of Outcomes: Vytorin Efficacy International Trial |
|
|
Incipient to Overt: Angiotensin II receptor blocker, Telmisartan, Investigation On type 2 diabetic Nephropathy |
|
|
Intracoronary Stenting and Antithrombotic Regimen: Safety And efficacy of six months dual antiplatelet therapy after drug-Eluting stenting |
|
|
Japanese Trial to assess Optimal Systolic blood pressure in elderly hypertensive patients |
|
|
Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension |
|
|
|
|
|
Kronos Early Estrogen Prevention Study |
|
|
Korean Health and Genome Study |
|
|
Lower Extremity Arterial Disease Event Reduction |
|
|
Action for Health in Diabetes |
|
|
Melatonin Adjunct in the acute myocardial Infarction treated with Angioplasty |
|
|
Myocardial Infarction Secondary Prevention Study |
|
|
Media Intima Thickness Evaluation of Candesartan |
|
|
Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research |
|
|
|
|
|
Prevention by low dose Aspirin of Cardiovascular disease in the Elderly |
|
|
Paracetamol (Acetaminophen) In Stroke |
|
|
Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions |
|
|
Randomized Angiotensin receptor antagonist – ACE inhibitor Study |
|
|
Resource utilization Among Congestive Heart failure |
|
|
Risk factors, Evaluation of Coronary Calcium and Lifestyle |
|
|
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycaemia in Diabetes |
|
|
Reasons for Geographic And Racial Differences in Stroke |
|
|
Renin-Aldosterone |
|
|
Randomised Olmesartan And Diabetes Microalbuminuria Prevention |
|
|
Stop Atherosclerosis in Native Diabetics Study |
|
|
Shock Inhibition Evaluation with Azimilide |
|
|
Telmisartan Effectiveness on Left ventricular Mass Reduction |
|
|
Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure |
|
|
Thrombolysis in Cardiac Arrest |
|
|
Valsartan Cardio-Renal Protection |
|
|
Valsartan In Diastolic Dysfunction |
|
|
Valsartan in elderly Isolated Systolic Hypertension |
|
|
Women’s Antioxidant Cardiovascular Study |
|
